IceCure Medical reported a gross margin of 27.89% and a net margin of 487.76% for the quarter ended Jun 2026. These financial ratios cover 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||
| Gross Margin | 52.72% | 46.46% | 58.10% | 50.20% | 26.18% | 49.09% | 45.07% | 46.32% | -7.03% | 45.34% | 36.20% | 52.42% | 35.50% | 47.66% | 30.07% | 24.95% | 32.59% | 46.91% | 32.38% | 27.89% | ||||
| EBT Margin | 418.50% | 226.01% | 592.37% | 559.61% | 646.85% | 418.74% | 557.32% | 435.54% | 1,260.86% | 272.11% | 491.25% | 319.29% | 648.49% | 517.14% | 504.41% | 644.76% | 451.29% | 329.63% | 466.19% | 487.76% | ||||
| EBIT Margin | 418.50% | 226.01% | 592.37% | 559.61% | 646.85% | 418.74% | 557.32% | 435.54% | 1,260.86% | 272.11% | 491.25% | 319.29% | 648.49% | 517.14% | 504.41% | 644.76% | 451.29% | 329.63% | 466.19% | 487.76% | ||||
| EBITDA Margin | 418.50% | 226.01% | 592.37% | 559.61% | 646.85% | 418.74% | 557.32% | 435.54% | 1,260.86% | 272.11% | 491.25% | 319.29% | 648.49% | 517.14% | 504.41% | 644.76% | 451.29% | 329.63% | 466.19% | 487.76% | ||||
| Operating Margin | 418.50% | 226.01% | 592.37% | 559.61% | 646.85% | 418.74% | 557.32% | 435.54% | 1,260.86% | 272.11% | 491.25% | 319.29% | 648.49% | 517.14% | 504.41% | 644.76% | 451.29% | 329.63% | 466.19% | 487.76% | ||||
| Net Margin | 418.50% | 226.01% | 592.37% | 559.61% | 646.85% | 418.74% | 557.32% | 435.54% | 1,260.86% | 272.11% | 491.25% | 319.29% | 648.49% | 517.14% | 504.41% | 644.76% | 451.29% | 329.63% | 466.19% | 487.76% | ||||
| FCF Margin | -446.70% | -413.01% | -390.36% | -449.15% | -476.50% | -428.97% | -378.45% | -416.12% | -997.25% | -177.13% | -380.08% | -233.14% | -471.45% | -478.86% | -556.14% | -531.43% | -317.88% | -392.03% | -463.23% | -426.35% | ||||
| Efficiency | ||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 1.62M | 1.86M | 2.14M | 2.49M | 2.67M | 2.78M | 2.89M | 2.84M | 2.70M | 2.46M | 2.19M | 2.04M | 1.98M | 1.98M | 2.01M | 2.18M | 2.52M | 2.67M | 2.64M | 2.60M | ||||
| Assets AverageAssets Avg. | 20.67M | 25.98M | 30.50M | 26.26M | 21.95M | 25.14M | 28.53M | 24.79M | 21.06M | 17.92M | 16.23M | 15.71M | 15.32M | 13.93M | 11.84M | 10.85M | 12.83M | 14.48M | 13.60M | 15.51M | ||||
| Invested CapitalInvested Cap. | 14.63M | 27.58M | 23.58M | 19.42M | 15.76M | 25.85M | 22.39M | 18.84M | 15.17M | 12.54M | 11.95M | 10.88M | 10.28M | 7.06M | 6.11M | 4.96M | 9.33M | 9.06M | 8.50M | 11.92M | ||||
| Asset Utilization RatioAsset Util. | 0.20 | 0.16 | 0.11 | 0.14 | 0.16 | 0.12 | 0.11 | 0.13 | 0.14 | 0.18 | 0.20 | 0.21 | 0.24 | 0.24 | 0.28 | 0.26 | 0.23 | 0.23 | 0.26 | 0.25 | ||||
| Leverage & Solvency | ||||||||||||||||||||||||
| Debt Ratio | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Valuation | ||||||||||||||||||||||||
| Price to EarningsP/E | 62.43 | 27.84 | 15.48 | 11.40 | 8.98 | 14.59 | 10.76 | 10.52 | 4.85 | 14.33 | 15.03 | 10.48 | 6.50 | 13.75 | 18.19 | 16.64 | 14.97 | 10.58 | 5.18 | 2.68 | ||||
| Price to SalesP/S | 261.26 | 62.91 | 91.72 | 63.81 | 58.09 | 61.10 | 59.96 | 45.83 | 61.13 | 38.99 | 73.86 | 33.47 | 42.14 | 71.12 | 91.76 | 107.32 | 67.55 | 34.87 | 24.16 | 13.06 | ||||
| Price to BookP/B | 12.88 | 3.23 | 2.98 | 2.59 | 2.41 | 2.26 | 1.93 | 2.33 | 1.35 | 4.02 | 4.72 | 3.19 | 2.77 | 9.02 | 11.09 | 19.49 | 6.17 | 4.93 | 2.59 | 1.00 | ||||
| Enterprise Value | 162.54M | 61.45M | 46.16M | 31.09M | 24.10M | 33.42M | 36.68M | 26.26M | 15.87M | 48.43M | 43.91M | 23.38M | 17.22M | 54.66M | 60.49M | 50.96M | 47.41M | 35.71M | 13.89M | -0.19M | ||||
| EV to EBIT | 57.03 | 19.65 | 10.43 | 7.26 | 5.88 | 8.50 | 9.27 | 6.43 | 3.85 | 14.18 | 12.03 | 7.24 | 4.01 | 12.08 | 16.54 | 15.05 | 12.36 | 8.47 | 3.27 | -0.04 | ||||
| EV to EBITDA | 57.03 | 19.65 | 10.43 | 7.26 | 5.88 | 8.50 | 9.27 | 6.43 | 3.85 | 14.18 | 12.03 | 7.24 | 4.01 | 12.08 | 16.54 | 15.05 | 12.36 | 8.47 | 3.27 | -0.04 | ||||
| Market Capitalization | 177.92M | 87.07M | 68.52M | 48.82M | 36.83M | 57.38M | 42.57M | 42.94M | 19.99M | 48.93M | 54.88M | 33.84M | 27.90M | 62.23M | 66.53M | 56.34M | 57.42M | 44.60M | 22.01M | 11.85M | ||||
| Price to FCFP/FCF | -58.49 | -15.23 | -23.50 | -14.21 | -12.19 | -14.24 | -15.84 | -11.01 | -6.13 | -22.01 | -19.43 | -14.36 | -8.94 | -14.85 | -16.50 | -20.19 | -21.25 | -8.90 | -5.22 | -3.06 | ||||
| EV to FCF | -53.43 | -10.75 | -15.83 | -9.05 | -7.98 | -8.30 | -13.65 | -6.74 | -4.87 | -21.78 | -15.55 | -9.92 | -5.52 | -13.05 | -15.00 | -18.27 | -17.55 | -7.12 | -3.29 | 0.05 | ||||
| EV to CFO | -51.60 | -10.43 | -15.09 | -8.21 | -7.26 | -8.10 | -12.49 | -6.61 | -4.75 | -21.02 | -15.40 | -9.89 | -5.46 | -13.03 | -14.98 | -18.12 | -17.53 | -7.11 | -3.25 | 0.05 | ||||
| Return Ratios | ||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 418.50% | 226.01% | 592.37% | 559.61% | 646.85% | 418.74% | 557.32% | 435.54% | 1,260.86% | 272.11% | 491.25% | 319.29% | 648.49% | 517.14% | 504.41% | 644.76% | 451.29% | 329.63% | 466.19% | 487.76% | ||||
| Return on Capital Employed [ROCE]ROCE | 48.18% | 44.28% | 50.71% | 66.94% | 90.08% | 80.46% | 67.68% | 76.78% | 95.78% | 110.90% | 125.91% | 128.42% | 141.30% | 186.57% | 229.44% | 494.47% | 217.39% | 156.27% | 178.40% | 172.14% | ||||
| Return on Assets [ROA]ROA | 37.63% | 37.43% | 42.49% | 55.92% | 72.59% | 66.58% | 57.03% | 64.84% | 76.43% | 86.94% | 94.07% | 91.79% | 95.22% | 112.70% | 132.63% | 146.22% | 120.02% | 104.22% | 115.36% | 107.86% |